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ScienceDirectComposite health measures are increasingly applied in studies
aiming at describing the burden of diseases, and food and
water-borne diseases (FWDs) are no exception. The Burden of
Communicable Diseases in Europe (BCoDE) is a project led
and funded by the European Centre for Disease Prevention and
Control (ECDC) with the purpose of encouraging and
empowering public health experts in the estimation of the
impact of communicable diseases expressed in Disability
Adjusted Life Years (DALYs). Calculation of DALYs and a
critical assessment of burden of disease outputs require a
thorough consideration of a number of methodological and
epidemiological decisions ranging from modelling
(e.g. incidence versus prevalence), disease model parameters
(e.g. risks of developing complications or death) and the data
feeding the number of cases.Burden of disease studies
produce useful results for public health decision-making, in
particular when they aim at informing preventive strategies.
For this purpose, we attributed FWDs results from the BCoDE
2015 study to different exposure routes. We discuss these in
the more general perspective of generating burden of disease
evidence for planning and prioritisation, including the
potentials and limitations of its methodology.
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Introduction
Determining the public health impact of food and
water-borne diseases (FWDs) poses a number ofwww.sciencedirect.com challenges. Attempts to estimate such burden include
reporting of infections [1,2,3], incidence and
mortality [4]. However, severity, duration and mortali-
ty related to FWDs vary widely; therefore, a more
coherent and consistent approach is needed to enable
comparison between the overall impact of diseases.
Disability-adjusted life years (DALYs), a summary
measure of population health developed by the Global
Burden of Disease (GBD) study [5], match these
requirements and are increasingly utilised to inform
evidence-based health policy decision making
[6,7,8,9,10,11].
In 2006, the European Centre for Disease Prevention and
Control (ECDC) commissioned a pilot estimation of
seven selected infectious diseases (IDs) in order to
explore the interest in and feasibility of a burden of
infectious disease study and to layout its methodology
[12,13]. Based on this pilot investigation, the Burden of
Communicable Diseases in Europe (BCoDE) project
was launched. Funded by an ECDC grant and imple-
mented in collaboration with a European Consortium led
by the Dutch National Institute for Public Health and
the Environment (RIVM), the project included Europe-
an experts from academic centres and national health
institutes.
A consistent methodology for calculating the burden of
infectious diseases expressed in DALYs, pathogen and
incidence-based, was developed [14,15]. Results of the
burden of selected FWDs on European Union and
European Economic Area (EU/EEA) Member States,
amongst others, were recently presented at the
2015 European Public Health Conference [16] and
represent the findings of the BCoDE 2015 study
[17]. Using the BCoDE 2015 study as a reference
point, we provide an overview of, and a comparison
with other methodological frameworks and options for
burden of disease studies. With the purpose of inform-
ing risk assessment, we attributed the FWD disease-
specific DALYs stemming from BCoDE 2015 to dif-
ferent exposure routes as an example illustrating how
burden of disease outputs help inform public health
planning and decision-making. Finally, we discuss how
findings of burden of disease studies compare and how
these are useful in providing scientifically sound infor-
mation to risk managers and their decision making
process.Current Opinion in Food Science 2016, 12:21–29
22 Food safety sectionMethodologies for estimating burden of
foodborne and waterborne diseases
DALY is a composite metric quantifying the health
losses measured in years. It was first developed as a
composite health measure by the Global Burden of
Disease project within the World health Organization
(WHO) [18] and has evolved in time [5]. DALYs are
calculated by adding years of life lost due to premature
mortality (YLL) and years of life lived with a disability
(YLD), associated with a specific disease. The former is
based on the number of deaths associated with a disease,
where deaths are stratified by age and multiplied by
remaining life expectancy by age at death. YLDs are the
sum of all outcomes’ durations multiplied by their dis-
ability weights and the number of cases experiencing
that outcome. Therefore, DALYs express the impact of
the acute phase of diseases and their related short and
long-term outcomes.
ECDC has the objective of surveillance and providing
scientific advice on a number of communicable diseases
(CDs) according to Decision 1082/2013/EU of the Euro-
pean Parliament and of the Council [19], which are
subject to mandatory notification by EU/EEA countries
to The European Surveillance System (TESSy) [20].
Within the master list of all communicable diseases, a
selection of diseases were integrated in the BCoDE
toolkit [21], a stand-alone software application for calcu-
lation of DALYs. The diseases were selected by an ad hoc
working group of the ECDC Advisory Forum based on
based on data availability, perceived incidence, outbreak
potential and if the disease is vaccine-preventable with
widely used vaccines [22].
The GBD 2010 and 2013 studies utilised prevalence data
sources [23,24] whereas the BCoDE project modified
this methodology and suggested an incidence-based and
pathogen-based approach [14,15]. The effect of an inci-
dence approach is to acknowledge future sequelae of
infections on top of the disabilities due to the acute phase
of the disease. The incidence-based estimation of burden
also sets the baseline information for estimating the
impact of prevention and control interventions in a com-
prehensive way by accounting for the short and long-term
effects of interventions [25]. The pathogen approach
assigns the disease burden to a causal or associated event.
In practice, symptomatic infections are linked to out-
comes through a disease progression model and visually
described in outcome trees such as those displayed in the
BCoDE toolkit [21]. It is important to note that, as
shown by Schroeder [26], if DALYs are calculated with-
out time discounting (see below), the choice of a preva-
lence versus an incidence approach has a minimal impact
on the final results in a trend steady state situation [27].
Outcome tree parameters can be based on literature
reviews, observed clinical outcome data, or a mix ofCurrent Opinion in Food Science 2016, 12:21–29 the two. The BCoDE toolkit [21], for example, utilises
the latter approach and case fatality proportions extracted
from literature reviews were age-specifically modelled
according to notified deaths by age groups, through en-
hanced surveillance data reported to TESSy.
Disability weights quantify health losses relating to non-
fatal outcomes. Several sets of disability weights are
available, all based on different elicitation methods
[28]. The BCoDE toolkit utilises disability weights stem-
ming from the European disability weights study [29,30].
Other methodological choices that need to be considered
include time discounting and age weighting. The
BCoDE toolkit users have the option to calculate DALYs
with or without time discounting, as well as choosing the
annual rate. Time discounting is particularly used in
economic assessments and burden of disease studies
aiming at estimating the economic impact of a disease
or an intervention. For the BCoDE 2015 study, time
discounting was not included as the purpose of the study
was to estimate the impact of infectious diseases on the
health of European citizens and not on its economy. In
that sense, it was considered that there were no particular
reasons why future health effects should be valued less:
utilities associated to healthy life years were assumed not
to decline over time [31]. Similar considerations are valid
for age weighting, which has been suggested as a way to
account for societal priorities. The BCoDE methodology
proposes an approach aiming at measuring the impact of
infectious diseases on health. Moreover, if societal priori-
ties were to be measured when calculating DALYs, age
weighting would provide incomplete and biased informa-
tion. Therefore, it was decided to exclude age weighting
from the BCoDE toolkit. In conclusion, for the BCoDE
2015 study, disabilities and healthy life were treated
equally regardless of age and time.
Ranges of values reflecting variability and uncertainty can
be defined within all parameters of the BCoDE toolkit.
DALYs are then calculated through Monte Carlo simula-
tions for which the number of iterations is set by the user.
The resulting 95% uncertainty intervals (UI) are dis-
played in the results.
Choice of data sources: striking a very thin
balance
When choosing the data source for determining inci-
dence, researchers strive to balance data availability
and quality with representativeness of the population
under study. As a secondary objective, the BCoDE
2015 study aimed at exploring and describing the features
of the ECDC surveillance system. Therefore, TESSy was
chosen as the default data source. In principle, the ap-
proach consisted in exporting age-group and sex specific
annual number of cases from TESSy’s case-base data-
base. EU/EEA MSs were considered according to data
availability (i.e. if cases were reported to TESSy) and towww.sciencedirect.com
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sory versus voluntary, comprehensive versus sentinel,
national coverage). In conclusion, differences of MS
reporting patterns need to be considered in light of the
European heterogeneity with regards to the surveillance
system, reporting qualities and epidemiological situa-
tions.
When estimating a baseline burden of disease, annual
epidemiological variations are particularly relevant due to
seasonality and outbreaks for example. Including several
years of surveillance data and averaging these to obtain
the annual number of cases, spreads the peak effect over
several years. For example, the BCoDE 2015 study aver-
aged cases notified to TESSy between 2009 and 2013 and
the Dutch Burden of infectious disease study averaged
reported cases between 2006 and 2013 [9].
Notification data are of good quality in Europe although
as usual prone to a varying degree of underestimation.
Underestimation stems from a combination of underre-
porting (infected individuals whose disease is misdiag-
nosed, misclassified or not reported to the national
surveillance system) and underascertainment (infected
individuals who never seek healthcare) [32]. Moreover,
the nature and the extent of the under-estimation effect
varies across countries and, at times, across epidemiologi-
cal years [33]. For the BCoDE 2015 study, extensive
literature reviews were undergone for each disease in
order to estimate multipliers adjusting for under-estima-
tion of reported data.
About 5.69 cases per 100,000 population of giardiasis were
reported in the EU/EEA which were multiplied by 14
(with a range from 4 to 49) [7,34]. The hepatitis A average
reporting rate of 2.78 per 100,000 population was multi-
plied by 4.5 (3.7–5.6) [35]. For listeriosis, a factor 1.7 (1.1–
2.3) was applied to the average notification rate of 0.41 per
100,000 population [7], for shigellosis the notified cases of
1.67 per 100,000 population were multiplied by 18.3 (2.9–
39.5) [7,36] and notified rates of verocytotoxigenic Escher-
ichia coli (STEC/VTEC) (1.31 per 100,000 population)
were multiplied by 26.68 (1.6–109.7) [7,34,37].
When notification data is scarce or unavailable, alternative
methods should also be considered, such as capture–
recapture studies, analysis of attack rates and serological
studies. For example, underestimation of notified cam-
pylobacteriosis and salmonellosis symptomatic cases was
estimated based on serological studies [1,38,39]. These
sero-incidence studies have determined the rate of infec-
tion in several EU Member States, which provides im-
portant information on the circulation of the infection.
For example, it was estimated that Salmonella cause
0.06–0.61 infections per person-year, respectively in
Sweden and Spain. These findings should not be con-
fused with symptomatic diseases. However, assumingwww.sciencedirect.com that the disease-to-infection rate is constant across
countries, sero-incidence studies are able to provide
useful information. In the BCoDE 2015 study, for the
estimation of symptomatic campylobacteriosis and salmo-
nellosis sero-incidence results of three EU Member
States (for Salmonella; two for Campylobacter) were an-
chored to community based studies performed in the
same countries [38]. Each anchoring provided a conver-
sion factor between infections and diseases, which were
applied to the other countries. The range of estimated
incident symptomatic cases was used to estimate the
burden in DALYs.
Another example describing a situation where notification
data is unavailable is the estimation of the incidence of
symptomatic congenital toxoplasmosis. A literature re-
search provided a range of 7.3–29 cases per 100,000 births
to which no multiplier adjusting for under-estimation was
applied.
In the BCoDE 2015 study, age-group and sex specific
incident cases and, where applicable, multipliers adjust-
ing for under-estimation of notified cases were inserted in
the BCoDE toolkit. No time discounting was applied and
1000 Monte Carlo simulations were chosen. No modifica-
tions to the BCoDE toolkit outcome tree parameters were
applied and estimated DALYs were exported into tables
and graphs.
Ranking risks according to impact on health
measured in DALYs
The BCoDE 2015 found that campylobacteriosis was the
disease with the highest burden in the EU/EEA with 8.20
(UI: 6.68–10.01) DALYs per 100,000 population, followed
by salmonellosis with 3.96 (UI: 3.68–4.26) and infection
with Shiga toxin-producing E. coli (STEC) with 2.08 (UI:
2.59–3.21). These diseases represent more than 75% of
the burden of the FWDs under study and it was estimated
that slightly over 2000 deaths are associated with FWDs
in the EU/EEA every year. Moreover, congenital infec-
tions (congenital toxoplasmosis and perinatal listeriosis),
although rare, have a considerably high burden in new-
born population, suggesting the need to continue and
improve the existing preventive efforts in this vulnerable
population.
As a composite health measure, DALY provides a com-
prehensive overview of the impact of diseases as it
encompasses the relative disabilities and mortality, sus-
tained both during the acute phase and related to the
short and long-term complications of diseases. These are
the reasons underlying the European Food Safety
Authority’s (EFSA) recommendation on using the
BCoDE toolkit, and the BCoDE methodological ap-
proach, as part of the risk ranking toolbox for the Panel
on Biological Hazards (BIOHAZ) [40], in particular as a
top-down method to rank pathogens.Current Opinion in Food Science 2016, 12:21–29
24 Food safety sectionThe bubble chart in Figure 1 illustrates how the resulting
DALYs per 100,000 for each disease relate to their inci-
dence and estimated deaths. For example, the high
burden of campylobacteriosis is a result of both high
incidence and number of associated deaths. The burden
of listeriosis is mainly due to its mortality, as opposed to
giardiasis. This bubble chart shows more clearly that the
choice of indicator affects very much the final ranking of
diseases and the ensuing interpretation of the impact on
population health.
Several burden of disease studies have estimated DALYs
for FWDs at the national level [41,42] and comparing the
same FWD across different countries [43]. Studies with a
similar methodology to the BCoDE 2015 study include
the Ontario Burden of Infectious Disease Study
(ONBOIDS) [44] and the World Health Organization
(WHO) Foodborne Disease Burden Epidemiology Ref-
erence Group (FERG) [45,46]. Whilst comparing the
same diseases, the former found an overall burden of
3.28 DALYs per 100,000 population in contrast to our
finding of 18.76. Estimated incidence was similar in both
studies (475–832 cases per 100,000 population in BCoDE
2015 versus 726 in ONBOIDS), as well as risks of devel-
oping complications. However, the ONBOIDS study
estimated 0.33 annual deaths attributable to Campylobac-
ter enteritis, resulting in a case fatality proportion (CFP)Figure 1
Salmonellosi
Listeriosis
0.20
0.16
0.12
0.08
0.04
0.00
0 100 200 300
STEC/VTEC
Annual incidence per
An
nu
al
 d
ea
th
s 
pe
r 1
00
,0
00
 to
ta
l p
op
ul
at
io
n
GiardiasisCT
Shigellosis
Hepatitis A
From BCoDE 2015: bubble chart plotting the DALYs per 100,000 (diameter 
deaths per 100,000 total population from the BCoDE toolkit disease models
burden).
Current Opinion in Food Science 2016, 12:21–29 of 0.0004% while BCoDE 2015 was set a CFP of 0.001–
0.05%. As an effect, YLLs for campylobacteriosis was
higher in the BCoDE 2015 study, representing 40% of the
total burden against 15% in ONBOIDS. In terms of
ranking, however, campylobacteriosis and salmonellosis
consistently ranked as the foodborne diseases with the
highest burden.
A global study of FWDs, the WHO FERG endeavour,
offers results of burden of pathogens in different WHO
subregions [45,47]. For comparison with our findings
we considered EUR A region and found a higher burden
of all comparable FWDs from the FERG study compared
to BCoDE 2015: 26.62 (UI: 22.03–40.80) versus 19.14 (UI:
16.20–22.67) DALYs per 100,000 population. Main dif-
ferences, both in terms of ranking and DALY per 100,000,
are related to non-typhoidal Salmonella enterica (ranked
first in the FERG study with 12 (UI: 7–18) DALYs per
100,000 population) and to Shiga toxin-producing E. coli
(ranked 5th with 0.6 (95% UI: 0.2–1) DALYs per 100,000
population).
Incidence of STEC is similar across the two studies which
both apply a set of multiplication factors adjusting for
underestimation to notification data [48]: FERG applied
the factor of 36 (with a range of 7.4–106.8) [49] whereas
BCoDE 2015 chose the factor of 26.68 (with a range ofs
400 500 600 700
 100,000 total population
Campylobacteriosis
Current Opinion in Food Science 
of bubble) with incidence per 100,000 total population and estimated
. (CT = congenital toxoplasmosis; vCJD is not visible given the low
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regional incidence of STEC incidence in the EUR A
region of 47.1 cases per 100,000 population, not very
dissimilar to our finding of 35 cases per 100,000 popula-
tion. When comparing the STEC disease model (out-
come tree) of BCoDE present in the ECDC BCoDE
toolkit software application [21] with that of the FERG
study, they appear to include the same outcomes, except
renal transplantation present in BCoDE. However, risk of
developing haemolytic uraemic syndrome (HUS) and
end-stage renal disease (ESRD) is higher in BCoDE
2015 than in the FERG study (age dependent interval
of 0.94–1.25% [21] against 0.03–0.8% [49] for HUS and
2.9–10.5% [21] against 3% (ranging from 0% to 30%) [49]
for ESRD, respectively).
Differences in the salmonellosis results between the two
studies seem more complex and possibly related to a
combination of three factors. The FERG study inputted a
higher incidence (301.5 per 100,000 population versus
216 per 100,000 population in BCoDE 2015 study), a
higher proportion of moderate diarrhoea (25% against
15% [44], respectively) and a higher disability weight
applied to the diarrhoeal event (0.202 taken from GBDFigure 2
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www.sciencedirect.com 2010 against 0.149 applied in BCoDE 2015). Moreover,
one substantial difference, which might explain the
higher burden in FERG study, is related to choices
concerning the CFP. The ECDC BCoDE mortality
per 100,000 upper range is lower (0.17 against 0.40 DALYs
per 100,000 population) although median values are the
same (0.16 against 0.15 DALYs per 100,000 population).
However, the BCoDE disease model applied an age-
group re-distribution of the CFP (stemming from en-
hanced surveillance information from TESSy) where
nearly 70% of the deaths occur in people older than
70 years, resulting in lower YLLs from death associated
to salmonellosis.
Attribution of infection to exposure routes
Attribution of the BCoDE 2015 FWDs to different ex-
posure pathways was based on a recent global elicitation
study, funded by the World Health Organization (WHO),
within the framework of the Foodborne Disease Burden
Epidemiology Reference Group (FERG) [50]. Major
transmission routes were through food, animal contact
(domestic and wild), human to human transmission,
water, soil or other. For the present study, we only
considered median values and 95% uncertainty intervalsan to human Water Soil Other
0% 50% 60% 70% 80% 90% 100%
Current Opinion in Food Science 
posure routes according to WHO FERG expert elicitation (subregion
Current Opinion in Food Science 2016, 12:21–29
26 Food safety sectionresults for WHO subregion EUR A (European Region,
Stratum A).
Figure 2 presents the attribution of the burden of FWDs
to different exposure groups. As expected, estimation of
DALYs by different exposure routes shows that most of
the burden was attributed to food as the main cause of
transmission, 77% (uncertainty ranging from 40% to
100%), suggesting the need to strengthen efforts to
control and prevent FWDs through interventions in
the food chain. For example, campylobacteriosis is the
most commonly reported FWD and its trend has been
increasing in the past years [3,4]. Recent studies also
show that in some European countries up to 80% of the
population are infected with Campylobacter every year,
although not all develop a symptomatic disease [2].
EFSA has estimated that 50–80% of human Campylobac-
ter infections can be attributed to the chicken as a reser-
voir, warranting appropriate prevention measures to be
applied along the poultry food chain [51]. In 2012, EFSA
has published options for interventions at poultry meat
inspection with the aim to reduce the public health risk
for Campylobacter, Salmonella and ESBL/AmpC gene-
carrying bacteria [52].Figure 3
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Current Opinion in Food Science 2016, 12:21–29 This information is potentially useful for improving pre-
vention strategies in EU/EEA countries, especially in
light of the planned further work on specific food
sources/categories (personal communication, Tine Hald).
However, the FERG study did not specifically explore
the differential exposures according to age groups.
Figure 3 clearly illustrates that young children under
5 years of age are the age group at highest risk for
FWD. Infection pathways in this age category might
differ, which might undermine the effectiveness of inter-
ventions aiming at preventive efforts.
Burden of disease studies for planning and
prioritisation
Estimation of incidence, involving critical assessments of
data quality and degrees of under-estimation of reported
surveillance data, is a crucial factor in the calculation of
burden of disease in DALYs. Likewise, assumptions and
decisions underlying the choice of incidence to input in
the disease models are decisive in the interpretation of
the results. As discussed above, all parameters of the
disease models will also play a fundamental role in the
DALY results, along with modelling decisions. These
assumptions have to be accounted for when interpreting0 80.00 100.00 120.00
Current Opinion in Food Science 
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studies, in particular for planning and prioritisation pur-
poses during which communication of limitations and
uncertainties become a complex but necessary task.
For this reason, integrative methods of risk ranking and
prioritisation are highly recommended. Examples under-
taken from National Health Authorities include prioriti-
sation exercises for surveillance purposes in Germany and
Sweden [53,54]. Both studies report that infections from
Campylobacter spp., Salmonella spp. and Shiga-toxin pro-
ducing E. coli should be placed in the highest priority
group. This is consistent with our findings, which ranked
the diseases resulting from those infections as those with
the highest burden. Moreover, listeriosis was consistently
ranked as being in the high priority group. The remaining
infections move between high and medium priority group
depending on the study.
ECDC continues working on risk ranking methodologies
[55] and is developing a framework for emerging threats
impact assessment based on multi-criteria decision anal-
ysis (MCDA) methodologies [56,57]. The underlying
rationale is that quantitative methods alone, such as
burden of disease outputs in DALYs, do not fully encom-
pass all unknowns, uncertainties, variability and other
‘softer’ criteria such as public perception. On the other
hand, MCDA risk ranking methods are subject to a
certain degree of subjectivity, which may bias results.
DALY estimates of disease burden provide valuable
information to be taken into account during public health
decision-making for prevention strategies. Efforts aiming
at improving surveillance data availability and quality will
increase the precision and reliability of DALY estimates,
and of infectious disease modelling efforts in general.
Finally, DALYs can be one of the key inputs in compre-
hensive tools for risk ranking such as multi-criteria deci-
sion analysis.
Author contributions
AC wrote the first draft of the manuscript. All authors
helped conceive the opinion and contributed to writing
the manuscript.
Acknowledgements
We would like to acknowledge our colleagues Therese Westrell and Mike
Catchpole (ECDC) for their valuable input. We also acknowledge Marie-
Josee Mangen (Julius Centre for Health Sciences and Primary Care,
University Medical Centre Utrecht, Utrecht, the Netherlands) and Arie
Havelaar (University of Florida, Gainesville, Florida, United States of
America) for their contributions related to the BCoDE project. No external
funding was required for this research.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.cofs.2016.06.
002.www.sciencedirect.com References and recommended reading
Papers of particular interest, published within the period of review,
have been highlighted as:
 of special interest
 of outstanding interest
1.

Mølbak K, Simonsen J, Jørgensen CS, Krogfelt KA, Falkenhorst G,
Ethelberg S et al.: Seroincidence of human infections with
nontyphoid Salmonella compared with data from public health
surveillance and food animals in 13 European countries. Clin
Infect Dis 2014, 59:1599-1606.
The authors developed a mathematical model allowing calculation of the
annual incidence of Salmonella infections based on the decay of anti-
bodies present in the serum. The model was applied to samples repre-
senting the general population in 13 countries of the European Union.
Ten-fold variations were found across countries and no correlation with
official notification data from national surveillance systems was estab-
lished.
2. Teunis PF, Falkenhorst G, Ang CW, Strid MA, De Valk H,
Sadkowska-Todys M et al.: Campylobacter seroconversion
rates in selected countries in the European Union. Epidemiol
Infect 2013, 141:2051-2057.
3. Emborg HD, Teunis P, Simonsen J, Krogfelt KA, Jorgensen CS,
Takkinen J et al.: Was the increase in culture-confirmed
Campylobacter infections in Denmark during the 1990s a
surveillance artefact? Euro Surveill 2015, 20.
4. EFSA (European Food Safety Authority) and ECDC (European
Centre for Disease Prevention and Control): The European Union
summary report on trends and sources of zoonoses, zoonotic
agents and food-borne outbreaks in 2014. EFSA J 2015, 12:191.
5. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C
et al.: GBD 2010: design, definitions, and metrics. Lancet 2012,
380:2063-2066.
6. Havelaar AH, Haagsma JA, Mangen MJ, Kemmeren JM,
Verhoef LP, Vijgen SM et al.: Disease burden of foodborne
pathogens in the Netherlands, 2009. Int J Food Microbiol 2012,
156:231-238.
7. Gkogka E, Reij MW, Havelaar AH, Zwietering MH, Gorris LG: Risk-
based estimate of effect of foodborne diseases on public
health, Greece. Emerg Infect Dis 2011, 17:1581-1590.
8. Batz MB, Hoffmann S, Morris JG: Ranking the risks: The
10 pathogen-food combinations with the greatest burden on public
health. Gainesville, FL: Emerging Pathogens Institute, University of
Florida; 2011.
9. Bijkerk P, van Lier A, McDonald S, Kardamanidis K, Fanoy EB,
Wallinga J et al.: State of infectious diseases in the Netherlands,
2013. Bilthoven, The Netherlands: National Institute for Public
Health and the Environment, RIVM; 2014.
10. Global Burden of Disease Study C: Global, regional, and national
incidence, prevalence, and years lived with disability for
301 acute and chronic diseases and injuries in 188 countries,
1990–2013: a systematic analysis for the Global Burden of
Disease Study 2013. Lancet 2015, 386:743-800.
11.

Oostvogels AJ, De Wit GA, Jahn B, Cassini A, Colzani E, De
Waure C et al.: Use of DALYs in economic analyses on
interventions for infectious diseases: a systematic review.
Epidemiol Infect 2015, 143:1791-1802.
This article presents an overview of the application of disability-adjusted life
years (DALYs) in health economics and in particular for the economic
assessment of infectious disease interventions. Economic methodologies
applied to DALYs have increased in the past 10 years, although most
studies were conducted in low-income countries. However, many studies
analysed in the systematic review did not fully adhere to the recommended
methodologies, ultimately undermining comparability across studies.
12. van Lier EA, Havelaar AH, Nanda A: The burden of infectious
diseases in Europe: a pilot study. Euro Surveill 2007, 12:E3-E4.
13. Jakab Z: Why a burden of disease study? Euro Surveill 2007,
12:E1-E2.
14. Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM,
Longhi S et al.: New methodology for estimating the burden of
infectious diseases in Europe. PLoS Med 2012, 9:e1001205.Current Opinion in Food Science 2016, 12:21–29
28 Food safety section15. Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A,
Muhlberger N et al.: The pathogen- and incidence-based DALY
approach: an appropriate [corrected] methodology for
estimating the burden of infectious diseases. PLOS ONE 2013,
8:e79740.
16. Colzani E: Results from the 2015 Burden of Communicable
Diseases in Europe (BCoDE) study. European public health
conference; Milan: 2015.
17. Cassini ACE, Pini A, Maringhini G, Mangen MJJ, Plass D et al.:
Impact of infectious diseases in the European Union and European
Economic Area: results from the Burden of Communicable
Diseases in Europe (BCoDE) 2015 study. 2016:. [in preparation].
18. Murray CJ, Lopez AD: Global mortality, disability, and the
contribution of risk factors: Global Burden Of Disease Study.
Lancet 1997, 349:1436-1442.
19. European Parliament Council: DECISION No 1082/2013/EU of
22 October 2013 on serious cross-border threats to health and
repealing Decision No 2119/98/EC. Strasbourg: Official Journal of
the European Union; 2013.
20. The European Surveillance System: European Centre for Disease
Prevention and Control.
21.

ECDC BCoDE toolkit [software, application]. 1.2 ed.. Stockholm:
European Centre for Disease Prevention and Control; 2015.
The Burden of Communicable Disease in Europe (BCoDE) project, ran by
the European Centre for Disease Prevention and Control (ECDC) pro-
duced a stand-alone software application, with a user-friendly interface
and an embedded tutorial, which allows calculation of disability-adjusted
life years (DALYs) for a selection of 32 communicable diseases and six
healthcare-associated infections. Calculations are based on inputted
incidence data from the user and disease models built in the application.
Outputs include graphs, bubble charts and tables.
22. Colzani E, Cassini ALD, Mangen MJJ, Plass D, McDonald SA et al.:
Improving the usability and communicability of burden of
disease methods and outputs: the BCoDE toolkit. Lancet 2016,
381.
23. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C
et al.: Disability-adjusted life years (DALYs) for 291 diseases
and injuries in 21 regions, 1990–2010: a systematic analysis for
the Global Burden of Disease Study 2010. Lancet 2012,
380:2197-2223.
24.

GBD 2013 DALYs and HALE Collaborators, Murray CJ,
Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F et al.:
Global, regional, and national disability-adjusted life years
(DALYs) for 306 diseases and injuries and healthy life
expectancy (HALE) for 188 countries, 1990–2013: quantifying
the epidemiological transition. Lancet 2015, 386:2145-2191.
The Global Burden of Disease Study 2013 (GBD 2013) generated global
summary measures of population health, including results of health loss
due to food-borne and water-borne diseases, allowing for comparative
epidemiological analysis across countries and time. Although DALYs for
infectious diseases have decreased, healthcare needs have not and
variations around burden of disease are not necessarily associated with
socio-demographic status.
25. Murray CLA, Rethinking DALYs: The Global Burden Of Disease: a
comprehensive assessment of mortality and disability from
diseases, injuries, and risk factors in 1990 and projected to 2020.
World Health Organization; 1996.
26. Schroeder SA: Incidence, prevalence, and hybrid approaches
to calculating disability-adjusted life years. Popul Health Metr
2012, 10:19.
27. Mangen MJJ, Plass D, Kretzschmar ME: Estimating the current
and future burden of communicable diseases in the European
Union and EEA/EFTA. . [Section 2.4.3] Bilthoven, The Netherlands:
National Institute for Public Health and the Environment; 2014.
28. Haagsma JA, Polinder S, Cassini A, Colzani E, Havelaar AH:
Review of disability weight studies: comparison of
methodological choices and values. Popul Health Metr 2014,
12:20.
29. Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T,
Havelaar AH, Cassini A et al.: Assessing disability weights based
on the responses of 30,660 people from four European
countries. Popul Health Metr 2015, 13:10.Current Opinion in Food Science 2016, 12:21–29 30. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S,
Havelaar AH et al.: Disability weights for the Global Burden of
Disease 2013 study. Lancet Glob Health 2015, 3:e712-e723.
31. Anand S, Hanson K: Disability-adjusted life years: a critical
review. J Health Econ 1997, 16:685-702.
32. Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ,
Kramarz P et al.: Measuring underreporting and under-
ascertainment in infectious disease datasets: a comparison of
methods. BMC Public Health 2014, 14:147.
33. Stein CE, Birmingham M, Kurian M, Duclos P, Strebel P: The
global burden of measles in the year 2000 – a model that uses
country-specific indicators. J Infect Dis 2003, 187(Suppl. 1):S8-
S14.
34. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR
et al.: Longitudinal study of infectious intestinal disease in the
UK (IID2 study): incidence in the community and presenting to
general practice. Gut 2012, 61:69-77.
35. Haagsma JA, Van Der Zanden BP, Tariq L, van Pelt W, van
Duynhoven YTPH, Havelaar AH: Disease burden and costs of
selected foodborne pathogens in the Netherlands. Bilthoven, The
Netherlands: Centre for Infectious Disease Control, National
Institute for Public Health and the Environment; 2006.
36. Haagsma JA, Siersema PD, De Wit NJ, Havelaar AH: Disease
burden of post-infectious irritable bowel syndrome in The
Netherlands. Epidemiol Infect 2010, 138:1650-1656.
37. Havelaar AH, Van Duynhoven YT, Nauta MJ, Bouwknegt M,
Heuvelink AE, De Wit GA et al.: Disease burden in The
Netherlands due to infections with Shiga toxin-producing
Escherichia coli O157. Epidemiol Infect 2004, 132:467-484.
38. Cassini AMK, Emborg HD, Simonsen J, Teunis P, van Pelt W,
Takkinen J: Estimation of incidence of symptomatic
Salmonella and Campylobacter infections based on sero-
incidence in 13 European countries. European Scientific
Conference on Applied Infectious Disease Epidemiology
(ESCAIDE). Stockholm, Sweden: European Centre for Disease
Prevention and Control (ECDC); 2015, .
39. ECDC seroincidence R package [software application]. 1.0.4 ed..
Stockholm: European Centre for Disease Prevention and Control;
2015.
40.

EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards):
Scientific opinion on the development of a risk ranking toolbox
for the EFSA BIOHAZ Panel. EFSA J 2015, 1:131.
Risk ranking of biological hazards in food plays a crucial role for decision-
making in food safety management, particularly in a context of finite
resources where clear and evidence-based priorities are a necessity. No
universal methodology exists and a risk ranking toolbox was proposed in
this opinion, which recommends the Food and Drug Administration iRISK
tool for a bottom-up approach in combination with the BCoDE toolkit as a
top-down tool. These could be combined with a network of available
predictive microbiology tools, databases and information sources to form
a risk ranking toolbox.
41. van Lier A, McDonald SA, Bouwknegt M, group EPI,
Kretzschmar ME, Havelaar AH et al.: Disease burden of
32 infectious diseases in the Netherlands, 2007–2011. PLOS
ONE 2016, 11:e0153106.
42. Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A, Krause G
et al.: The disease burden of hepatitis B, influenza, measles
and salmonellosis in Germany: first results of the burden of
communicable diseases in Europe study. Epidemiol Infect
2014, 142:2024-2035.
43. Mangen M-J, Havelaar AH, Haagsma JA, Kretzschmar MEE: The
burden of Campylobacter-associated disease in six European
countries. Microb Risk Anal 2016.
44. Kwong JC, Ratnasingham S, Campitelli MA, Daneman N,
Deeks SL, Manuel DG et al.: The impact of infection on
population health: results of the Ontario burden of infectious
diseases study. PLoS ONE 2012, 7:e44103.
45.

Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ
et al.: World Health Organization global estimates and regional
comparisons of the burden of foodborne disease in 2010. PLoS
Med 2015, 12:e1001923.www.sciencedirect.com
Impact of food and water-borne diseases on European population health Cassini et al. 29Part of a collection related to the World Health Organization (WHO)
Foodborne Disease Burden Epidemiology Reference Group (FERG), this
article illustrates the global burden of foodborne diseases measured in
disability-adjusted life years (DALYs). Most frequent causes of foodborne
diseases are norovirus, Campylobacter spp. and non-typhoidal Salmo-
nella enterica, children bearing the majority of DALYs. WHO regional
results are also available, European regions being amongst those with the
lowest burden. In Europe, Toxoplasma gondii and Listeria monocyto-
genes also generate a high burden. Ranking of diseases according to their
burden on population health is valuable information for prioritization and
planning public health interventions.
46. Devleesschauwer B, Haagsma JA, Angulo FJ, Bellinger DC,
Cole D, Dopfer D et al.: Methodological framework for World
Health Organization estimates of the global burden of
foodborne disease. PLOS ONE 2015, 10:e0142498.
47.

Kirk MD, Pires SM, Black RE, Caipo M, Crump JA,
Devleesschauwer B et al.: Correction: World Health
Organization estimates of the global and regional disease
burden of 22 foodborne bacterial, protozoal, and viral
diseases, 2010: a data synthesis. PLoS Med 2015, 12:e1001940.
Also part of the WHO FERG effort, this article provides detailed informa-
tion on the global and WHO regional annual number of cases, number of
deaths and DALYs for foodborne diseases. Estimates were based on
disease models encompassing all outcomes related to specific food-
borne infections. Systematic literature reviews were performed in order to
inform the disease models; these reviews are valuable for other research-
ers looking into modelling of infectious diseases. Moreover, age specific
results are also illustrated.
48. Pires SM, Fischer-Walker CL, Lanata CF, Devleesschauwer B,
Hall AJ, Kirk MD et al.: Aetiology-specific estimates of the
global and regional incidence and mortality of diarrhoeal
diseases commonly transmitted through food. PLOS ONE
2015, 10:e0142927.
49. Majowicz SE, Scallan E, Jones-Bitton A, Sargeant JM, Stapleton J,
Angulo FJ et al.: Global incidence of human Shiga toxin-
producing Escherichia coli infections and deaths: a
systematic review and knowledge synthesis. Foodborne
Pathog Dis 2014, 11:447-455.
50.

Hald T, Aspinall W, Devleesschauwer B, Cooke R, Corrigan T,
Havelaar AH et al.: World Health Organization estimates of the
relative contributions of food to the burden of disease due to
selected foodborne hazards: a structured expert elicitation.
PLOS ONE 2016, 11:e0145839.
Foodborne diseases are not only transmitted by food. This study explores
the different exposure routes: animals, humans, water and other envir-
onmental routes. Based on a worldwide expert elicitation study, the FERGwww.sciencedirect.com group estimated the relative contribution of the different exposure routes
to the burden of foodborne diseases.
51. (BIOHAZ) EPoBH: Scientific opinion on quantification of the
risk posed by broiler meat to human campylobacteriosis in the
EU. EFSA J 2010, 8:89.
52. EFSA Panels on Biological Hazards (BIOHAZ) oCitFCC, and on
Animal Health and Welfare (AHAW): Scientific opinion on the
public health hazards to be covered by inspection of meat
(poultry). EFSA J 2012, 10:179.
53.

Dahl V, Tegnell A, Wallensten A: Communicable diseases
prioritized according to their public health relevance, Sweden,
2013. PLOS ONE 2015, 10:e0136353.
The authors describe the methods and results of a Delphi process aiming
at prioritizing infectious diseases according to their public health rele-
vance. Authors found that most of the epidemiologists’ time working on
surveillance was spent on pathogens in the highest priority group. How-
ever, information on microbiology typing was not collected for many
pathogens in this group. This exercise also allowed for evaluating the
relevance of surveilling pathogens in the low priority group.
54. Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T,
Gartner B et al.: Communicable diseases prioritized for
surveillance and epidemiological research: results of a
standardized prioritization procedure in Germany, 2011. PLoS
ONE 2011, 6:e25691.
55.

European Centre for Disease Prevention and Control (ECDC): Best
practices in ranking emerging infectious disease threats.
Stockholm: ECDC; 2015.
Cross-border infectious disease outbreaks pose a threat to European
citizen’s health and require prioritisation of the relevant pathogens. This
review of the literature illustrates a range of methods used for prioritisation
and ranking of threats purposes. Methodologies described, including
strengths and limitations, are bibliometric index, the Delphi technique,
multi-criteria decision analysis (MCDA), qualitative algorithms, and ques-
tionnaires. A common approach to risk ranking methodologies were:
identifying diseases for ranking, identifying assessment criteria, weighting
criteria, scoring diseases against criteria, and producing a ranked list of
diseases.
56. Marsh K, Dolan P, Kempster J, Lugon M: Prioritizing investments
in public health: a multi-criteria decision analysis. J Public
Health 2013, 35:460-466.
57. Bouwknegt M, Neslo HA, de Roda HusmanAM R, Hogerwerf L, van
Steenbergen J et al.: Ranking infectious disease risks to
support preparedness prioritization in the European Union.
European Public Health Conference; Milan: 2015.Current Opinion in Food Science 2016, 12:21–29
